/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

ADMA BIOLOGICS INC

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$19.72 0.0244(2.44%) ADMA at 04 Dec 2025 04:25 PM Biotechnology
Lowest Today 19.335
Highest Today 20.14
Today’s Open 19.355
Prev. Close 19.25
52 Week High 25.67
52 Week Low 13.50
Day’s Range: Low 19.335 High 20.14
52-Week Range: Low 13.50 High 25.67
1 day return -
1 Week return +2.79
1 month return +34.78
3 month return +16.59
6 month return -3.07
1 year return -1.17
3 year return +508.17
5 year return +890.2
10 year return -

Institutional Holdings

BlackRock Inc 15.28

Vanguard Group Inc 8.95

iShares Core S&P Small-Cap ETF 5.95

Amvescap Plc. 5.37

State Street Corp 5.06

Vanguard Total Stock Mkt Idx Inv 3.00

Geode Capital Management, LLC 2.48

iShares Russell 2000 ETF 2.34

Nuveen, LLC 2.33

Dimensional Fund Advisors, Inc. 2.00

American Century Companies Inc 1.93

Allspring Global Investments Holdings, LLC 1.39

Thrivent Financial For Lutherans 1.39

SPDR® S&P Biotech ETF 1.36

FMR Inc 1.35

Renaissance Technologies Corp 1.32

Oberweis Asset Management Inc 1.31

Perpetual Ltd 1.21

Vanguard Small Cap Index 1.15

Franklin Resources Inc 1.14

American Century Small Cap Growth Inv 1.10

American Century U.S. Small Cap Growth 1.10

Vanguard Institutional Extnd Mkt Idx Tr 1.08

Charles Schwab Investment Management Inc 1.05

Driehaus Capital Management LLC 1.04

Northern Trust Corp 1.02

UBS Group AG 1.01

Ranger Investment Management LP 1.00

Fidelity Small Cap Index 0.97

SPDR® Portfolio S&P 600™ Sm Cap ETF 0.89

CREF Stock R3 0.86

iShares S&P Small-Cap 600 Growth ETF 0.86

iShares Russell 2000 Growth ETF 0.85

Invesco Main Street Small Cap R6 0.81

Thrivent Small Cap Stock A 0.80

Ranger Small Cap 0.79

Putnam Small Cap Growth A 0.73

Putnam US Small Cap Growth Equity 0.73

Putnam US Small Cap Growth Managed Acct 0.73

Invesco Small Cap Core 0.70

Market Status

Strong Buy: 2

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 4593.64 M

PB Ratio 10.5866

PE Ratio 22.3837

Enterprise Value 4586.54 M

Total Assets 488.68 M

Volume 2635028

Company Financials

Annual Revenue FY23:234292778 234.3M, FY22:154079692 154.1M, FY21:80942625 80.9M, FY20:42219783 42.2M, FY19:29349083 29.3M

Annual Profit FY23:72032654 72.0M, FY22:35265157 35.3M, FY21:1173284 1.2M, FY20:-19071643 -19.1M, FY19:-10155155 -10.2M

Annual Net worth FY23:-22826150 -22.8M, FY22:-85183323 -85.2M, FY21:-84452877 -84.5M, FY20:-87605086 -87.6M, FY19:-57045374 -57.0M

Quarterly Revenue Q3/2025:134224000 134.2M, Q2/2025:121984000 122.0M, Q1/2025:114802000 114.8M, Q3/2024:119839000 119.8M, Q2/2024:107191000 107.2M

Quarterly Profit Q3/2025:75626000 75.6M, Q2/2025:67227000 67.2M, Q1/2025:61097000 61.1M, Q3/2024:59659000 59.7M, Q2/2024:57311000 57.3M

Quarterly Net worth Q3/2025:36428000 36.4M, Q2/2025:34219000 34.2M, Q1/2025:26904000 26.9M, Q3/2024:35909000 35.9M, Q2/2024:32062000 32.1M

Fund house & investment objective

Company Information ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

Organisation Biotechnology

Employees 685

Industry Biotechnology

CEO Mr. Adam S. Grossman

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow